WINSTROL

Winstrol’s chemical structure differs very
significantly from every other anabolic steroid. It is,
however, a derivative of Dihydrotestosterone (DHT)
where it contains a 3-2 Pyrazol group attached to
the first cycloalkane ring (known as the A-ring) of
the anabolic steroid structure. This is actually very
noticeable when a picture of the chemical structure
of Winstrol is laid side-by-side with its progenitor
hormone DHT, even to an individual unfamiliar with
chemistry. The Pyrazol group’s attachment to the
A-ring actually replaces the 3-keto group that
normally sits in the same location. Specifically, this
major modification classifies Winstrol as what is
known as a Heterocyclic steroid.
This Pyrazol group, which is a functional group, is
actually responsible for Winstrol’s stronger binding
affinity for the androgen receptor in muscle tissue.
As a DHT-derivative with modifications that
separate its distinction with DHT, Winstrol is
actually active in muscle tissue to a far greater
degree than DHT itself is. Unfortunately, DHT itself
is rendered inactive almost immediately by two
enzymes upon its entrance into muscle tissue.
Winstrol’s modifications allow it to effectively avoid
this problem. All anabolic steroids that belong to the
family of DHT-derivatives (such as Winstrol, Anavar,
Primobolan, Masteron and several others) contain
modifications to their chemical structures that
grant them significant activity and effectiveness
within muscle tissue, where DHT itself unmodified
would never survive metabolism there. The Pyrazol
structure also grants Winstrol a significant shift in
its anabolic and androgenic strengths to favor more
of a stronger anabolic strength while greatly
reducing its androgenic strength. This is what
grants Winstrol with an incredibly strong
disassociation of anabolic to androgenic effects.